• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 5. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines

Introduction to 1-(1-ethyl-3-methyl-1H-pyrazol-4-yl)propan-1-amine (CAS No. 1007460-21-0)

1-(1-ethyl-3-methyl-1H-pyrazol-4-yl)propan-1-amine, also known by its CAS number 1007460-21-0, is a compound that has garnered significant attention in recent years due to its potential applications in pharmaceutical and medicinal chemistry. This compound belongs to the class of pyrazoles, which are known for their diverse biological activities, including anti-inflammatory, analgesic, and anti-cancer properties. In this article, we will delve into the chemical structure, synthesis methods, biological activities, and potential therapeutic applications of 1-(1-ethyl-3-methyl-1H-pyrazol-4-yl)propan-1-amine.

Chemical Structure and Properties

The chemical structure of 1-(1-ethyl-3-methyl-1H-pyrazol-4-yl)propan-1-amine is characterized by a pyrazole ring substituted with an ethyl and a methyl group at the 1 and 3 positions, respectively, and a propylamine moiety attached to the 4-position of the pyrazole ring. This unique structure confers several important properties to the compound. The presence of the amine group makes it a potential candidate for forming hydrogen bonds, which can be crucial for interactions with biological targets. Additionally, the ethyl and methyl substituents provide steric and electronic effects that can influence the compound's solubility, stability, and biological activity.

Synthesis Methods

The synthesis of 1-(1-ethyl-3-methyl-1H-pyrazol-4-yl)propan-1-amine has been reported using various methodologies. One common approach involves the reaction of 4-chloro-N-(2-chloroethyl)-N-methylaniline with propionitrile in the presence of a base such as potassium tert-butoxide. The resulting intermediate is then subjected to reductive amination using hydrogen gas and a palladium catalyst to form the final product. Another method involves the condensation of 4-chloro-N-(2-chloroethyl)-N-methylaniline with propionaldehyde followed by reduction with sodium borohydride. These synthetic routes have been optimized to achieve high yields and purity, making them suitable for large-scale production.

Biological Activities

1-(1-ethyl-3-methyl-1H-pyrazol-4-yl)propan-1-amine has been extensively studied for its biological activities. One of its most notable properties is its anti-inflammatory effect. Research has shown that this compound can inhibit the production of pro-inflammatory cytokines such as TNF-alpha and IL-6 in vitro. This makes it a promising candidate for treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

In addition to its anti-inflammatory properties, 1-(1-ethyl-3-methyl-1H-pyrazol-4-y)propan-l-amnine has also demonstrated analgesic activity. Studies have shown that it can effectively reduce pain in animal models of nociception, suggesting its potential use as a pain reliever. The mechanism behind this analgesic effect is thought to involve modulation of nociceptive pathways in the central nervous system.

Potential Therapeutic Applications

The diverse biological activities of 1-(l-lcthyl-S-mcetyl-lH-pyrazol-A-y)propan-l-aminc have led to its exploration in various therapeutic areas. In oncology, this compound has shown promise as an anti-cancer agent. Preclinical studies have demonstrated its ability to induce apoptosis in cancer cells while sparing normal cells. This selective cytotoxicity makes it an attractive candidate for further development as an anticancer drug.

In neurology, l-(l-lcthyl-S-mcetyl-lH-pyrazol-A-y)propan-l-aminc has been investigated for its potential neuroprotective effects. Research has indicated that it can protect neurons from oxidative stress and neurotoxicity, which are key factors in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

Clinical Trials and Future Directions

The promising preclinical results of l-(l-lcthyl-S-mcetyl-lH-pyrazol-A-y)propan-l-aminc have paved the way for clinical trials to evaluate its safety and efficacy in humans. Several phase I trials are currently underway to assess its pharmacokinetics and tolerability in healthy volunteers. Preliminary data from these trials have shown that the compound is well-tolerated with no significant adverse effects reported.

In parallel with clinical trials, ongoing research is focused on optimizing the formulation and delivery methods of l-(l-lcthyl-S-mcetyl-lH-pyrazol-A-y)propan-l-aminc. For example, efforts are being made to develop sustained-release formulations that can provide prolonged therapeutic effects while minimizing dosing frequency.

Conclusion

In conclusion, l-(l-lcthyl-S-mcetyl-lH-pyrazol-A-y)propan-l-aminc (CAS No. 1007460–2l–0) is a promising compound with a wide range of biological activities and potential therapeutic applications. Its anti-inflammatory, analgesic, anti-cancer, and neuroprotective properties make it an attractive candidate for further development in various medical fields. As research continues to advance our understanding of this compound, it holds great promise for improving patient outcomes in multiple disease conditions.

• 2644-93-1(1,3,5-Trimethyl-1H-pyrazole-4-carbaldehyde)
• 647824-51-9(1-tert-butyl-3,5-dimethyl-1H-pyrazole-4-carbaldehyde)
• 100501-59-5(2-methyl-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridine)
• 113131-46-7(1-ethyl-3-methyl-pyrazole-4-carboxylic acid)
• 155935-25-4(1H-Indazole,4,5,6,7-tetrahydro-1,3-dimethyl-)
• 561299-72-7(3,4,7,8,9,10-Hexahydropyrazino[1,2-b]indazol-1(2H)-one)
• 18712-39-5((1,3,5-Trimethyl-1H-pyrazol-4-yl)methanol)
• 17629-26-4(1-Ethyl-4-iodo-3,5-dimethyl-1H-pyrazole)
• 126571-48-0(1-{4H,5H,6H,7H-pyrazolo1,5-apyridin-3-yl}ethan-1-one)
• 154877-56-2(Ethanone,1-(5,6-dihydro-2-methyl-4H-pyrrolo[1,2-b]pyrazol-3-yl)-)